Novartis buys GSK business for up to $16bn in restructuring – Financial Times
The Guardian |
Novartis buys GSK business for up to bn in restructuring
Financial Times Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of the world's biggest drugmakers. GSK will sell its portfolio of cancer drugs to Novartis for up to bn and buy the Swiss group's vaccines … Lilly Announces Agreement to Acquire Novartis Animal Health GSK shuns talk of mega-mergers as it unveils 'complex' Novartis deal Novartis, GlaxoSmithKline Consumer-Health Business Unites Big Brands |
